Immunome Inc (IMNM) receives an Overweight rating from Stephens
Immunome Inc’s recently made public that its President and CEO SIEGALL CLAY B acquired Company’s shares for reported $0.63 million
Immunome Inc’s recently made public that its President and CEO SIEGALL CLAY B acquired Company’s shares for reported $0.63 million
Immunome Inc’s recent filing unveils that its President and CEO SIEGALL CLAY B acquired Company’s shares for reported $0.63 million
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Immunome Inc’s recently made public that its President and CEO SIEGALL CLAY B acquired Company’s shares for reported $0.63 million
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, Immunome Inc revealed its President and CEO SIEGALL CLAY B acquired Company’s shares for reported $0.63 million
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Immunome Inc’s recent filing unveils that its President and CEO SIEGALL CLAY B acquired Company’s shares for reported $0.63 million
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Immunome Inc’s recently made public that its Chief Financial Officer Rosett Max unloaded Company’s shares for reported $0.23 million on
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.